Although PERK is a controversial target in the context of neurodegenerative diseases, PDIA3 has been reported as an inhibitor of the PERK signaling pathway, suppressing PERK activation via PDI reduction [86]. This evidence concerns the gene EIF2AK3 and neurodegenerative disease.